CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

HeartSciences Inc.

HSCSW
$240K
Micro Cap
NASDAQFinance Services🇺🇸North AmericaSOUTHLAKE

Drugs in Pipeline

238

Phase 3 Programs

94

Upcoming Catalysts

0

Next Catalyst

None scheduled

Market Overview

Stock performance and key metrics

HSCSW News
Catalyst Timeline

0 upcoming, 0 past

No catalysts found.

Drug Pipeline

Aspirin 81mg

Phase 3

Pulmonary Disease, Chronic Obstructive

Hydroxyurea

Phase 3

Sickle Cell Disease

Metoprolol Tartrate

Phase 3

Heart Diseases

Spironolactone

Phase 3

Heart Failure

Fresh frozen plasma transfusion

Phase 3

Blood Coagulation Disorders

Sertraline/omega-3

Phase 3

Cardiovascular Diseases

5 mg Prednisone

Phase 3

Granulomatosis With Polyangiitis

Dapagliflozin Farxiga®

Phase 3

Dilated Cardiomyopathy

Oxygen

Phase 3

Acute Coronary Syndrome

Ginkgo biloba

Phase 3

Dementia

Diltiazem

Phase 3

Hypertrophic Cardiomyopathy

triamterene

Phase 3

Cardiovascular Diseases

Hydrocortisone

Phase 3

Cardiac Arrest

Ferric Derisomaltose 1000 Mg in 100 mL INTRAVENOUS SOLUTION [Monoferric]

Phase 3

Iron-deficiency

Bupropion HCl ER

Phase 3

Acute Coronary Syndrome

Mycophenolate Mofetil

Phase 3

Acute Myeloid Leukemia in Remission

Omega-3 Fatty Acids (Fish Oil Supplements)

Phase 3

Myocardial Infarction

Amiloride

Phase 3

Coronary Heart Disease

Tranexamic Acid

Phase 3

Thrombocytopenia

Darbepoetin

Phase 3

Neurocognitive

Mometasone 220mcg BID

Phase 3

Asthma

triamcinolone

Phase 3

Lung Diseases

Anakinra 100 mg

Phase 3

Acute Myocardial Infarction

Haploidentical Bone Marrow Transplant

Phase 3

Acute Lymphocytic Leukemia

Omega-3 Fatty Acid

Phase 3

Asthma

Isoquercetin

Phase 3

Thromboembolism of Vein VTE in Colorectal Cancer

Allogeneic bone marrow transplantation

Phase 3

Leukemia

Ethanol

Phase 3

Ventricular Tachycardia

Red Blood Cell Transfusion

Phase 3

Myocardial Infarction

Sacubitril-Valsartan 49 Mg-51 Mg Oral Tablet

Phase 3

Obesity

Salsalate

Phase 3

Coronary Artery Disease

Infasurf surfactant (ONY, Inc.)

Phase 3

Bronchopulmonary Dysplasia

Active Medication Alone

Phase 3

Cardiovascular Diseases

metoprolol succinate (Toprol XL)

Phase 3

Mitral Regurgitation

carotene

Phase 3

Cardiovascular Diseases

Pneumovax (PPSV23)

Phase 3

Pulmonary Disease, Chronic Obstructive

N-acetylcysteine (NAC)

Phase 3

Pulmonary Fibrosis

folic acid, vitamin B12 (cyanocobalamin), vitamin B6 (pyridoxine)

Phase 3

Coronary Artery Disease

intermediate dose Enoxaparin/ unfractionated heparin

Phase 3

Covid19

BRII-196

Phase 3

COVID-19

GLP-1 Low Dose

Phase 3

Type 2 Diabetes Mellitus

beclomethasone

Phase 3

Asthma

omega-3 fatty acids (fish oil)

Phase 3

Cancer

Transfusion

Phase 3

Sickle Cell Disease

Lutein/zeaxanthin and DHA/EPA

Phase 3

Age-related Macular Degeneration

Empagliflozin

Phase 3

Type2 Diabetes Mellitus

Zinc gluconate

Phase 3

Zinc Deficiency

disodium EDTA

Phase 3

Diabetes

Fosinopril

Phase 3

Microalbuminuria

Stepped pharmacologic care

Phase 3

Heart Failure

Albuterol sulfate

Phase 3

Asthma

beclomethasone HFA

Phase 3

Asthma

Maraviroc

Phase 3

HIV Infection

Lidocaine

Phase 3

Cardiac Arrest

antihypertensive agents

Phase 3

Cardiovascular Diseases

Tobramycin solution for inhalation

Phase 3

Cystic Fibrosis

Cisatracurium Besylate

Phase 3

Acute Respiratory Distress Syndrome

Perhexiline

Phase 3

Myocardial Reperfusion Injury

LTOWB

Phase 3

Wounds and Injuries

Triamcinolone 0.1%

Phase 3

Idiopathic Subglottic Stenosis

imipramine

Phase 3

Arrhythmia

HXe MRI guided treatment sequence for BT

Phase 3

Asthma

Mifepristone, Oral, 200 Mg

Phase 3

Missed Miscarriage

1:1:1 Blood Transfusion Ratio

Phase 3

Trauma

Red blood cell units stored <= 10 days

Phase 3

Cardiac Surgery

L-Arginine Hydrochloride

Phase 3

Sickle Cell Disease

VIR-7831

Phase 3

COVID-19

Udenafil

Phase 3

Single Ventricle Heart Disease

Biguanides, thiazolidinediones

Phase 3

Coronary Disease

streptokinase

Phase 3

Cardiovascular Diseases

Mono-Therapy with Sildenafil

Phase 3

Pediatric Pulmonary Hypertension

Caffeine citrate injection

Phase 3

Apnea of Prematurity

Nedocromil

Phase 3

Asthma

Albuterol

Phase 3

Congestive Heart Failure

AndroGel® (testosterone gel)

Phase 3

Andropause

Mineralocorticoid receptor antagonist potassium-canrenoate

Phase 3

ST-elevation Myocardial Infarction

TXA127

Phase 3

COVID-19

Polycap

Phase 3

Cardiovascular Disease

Milrinone infusion

Phase 3

Post-ligation Cardiac Syndrome

Sinerem administration

Phase 3

Aortic Aneurysm

Red Blood Cell

Phase 3

Sickle Cell Disease

mAb Nimotuzumab

Phase 3

Cervical Cancer Recurrent or Persistent

Convalescent Plasma

Phase 3

Covid19

thrombolytic therapy

Phase 3

Cardiovascular Diseases

Alpha-1 antitrypsin (AAT)

Phase 3

Graft Versus Host Disease (GVHD)

tissue plasminogen activator

Phase 3

Cardiovascular Diseases

Coversyl (perindopril)

Phase 3

Marfan Syndrome

Isosorbide Mononitrate XL (ISMN)

Phase 3

Cerebral Small Vessel Diseases

Rivaroxaban 15 MG

Phase 3

Left Ventricular Thrombus

Dietary Supplement/Vitamins

Phase 3

Preeclampsia

Nasal Fluticasone

Phase 3

Obstructive Sleep Apnea Syndrome

0.625 mg of conjugated equine estrogen

Phase 3

Heart Disease

Erythropoietin administration

Phase 3

Heart Failure, Congestive

Sirolimus + calcineurin inhibitor + prednisone

Phase 3

Chronic GVHD

Zuranolone

Phase 2

Post Stroke Depression

Dantrolene

Phase 2

Subarachnoid Hemorrhage

Ivacaftor 150 MG

Phase 2

Chronic Obstructive Pulmonary Disease

Transfused Biotin RBCs - Adults Phase I

Phase 2

Neonatal Anemia

2-Hydroxybenzylamine

Phase 2

Familial Hypercholesterolemia

Ascorbic Acid

Phase 2

Acute Lung Injury

Hyperpolarized 129Xe

Phase 2

Interstitial Lung Diseases

BNP (nesiritide)

Phase 2

Left Ventricular Diastolic Dysfunction

T Cell-Depleted Hematopoietic Stem Cell Transplantation

Phase 2

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive

Tofacitinib 10 MG [Xeljanz]

Phase 2

Diaphragm Injury

Ganirelix acetate

Phase 2

Orthostatic Intolerance

Antidepressant Medications

Phase 2

Depression

acebutolol

Phase 2

Cardiovascular Diseases

Prothrombin Complex Concentrate (PCC)

Phase 2

Bleeding

Inhaled Nitric Oxide (iNO)

Phase 2

Bronchopulmonary Dysplasia

Eicosapentaenoic acid (omega-3 fatty acid)

Phase 2

Schizophrenia

Active Comparator: Second Intervention (3 weeks)

Phase 2

Metabolic Syndrome X

Canagliflozin 300Mg Tab

Phase 2

ESRD, CKD Stage 4, CKD Stage 5

Niacinamide

Phase 2

Ischemia Reperfusion Injury

Fludarabine and Busulfan

Phase 2

Leukemia

64Cu-FBP8

Phase 2

Alzheimer Disease

Epoetin Alpha

Phase 2

Neonatal Anemia

bb2121

Phase 2

Multiple Myeloma

Autologous hMSCs

Phase 2

Non-ischemic Dilated Cardiomyopathy

Cannabis

Phase 2

Sickle Cell Disease

Activin ligand-trap biological therapy

Phase 2

Heart Failure With Preserved Ejection Fraction

Combination nicotine replacement therapy (Nicotine patch + nicotine mini-lozenge)

Phase 2

Tobacco Dependence

Omega-3 supplement

Phase 2

Depression

Oral Contraceptives, Low-Dose

Phase 2

Metabolic Syndrome

Enteral Vitamin D3 50,000 IU

Phase 2

Respiratory Failure

Doxycycline

Phase 2

Emphysema

Patent 2027

Propofol sedation

Phase 2

Obstructive Sleep Apnea

BCNU

Phase 2

Lymphoma

HST-NEETs

Phase 2

HIV Associated Lymphoma

Growth hormone releasing hormone (GHRH) 1-44

Phase 2

Abdominal Obesity

Compare change is SVC and SMA flow due to GIP antagonist GIP(3-30)NH2

Phase 2

Postural Tachycardia Syndrome (POTS)

MitoQ Compound

Phase 2

Dilated Cardiomyopathy

Enoxaparin + Rosuvastatin

Phase 2

Ovarian Cancer

Citrulline

Phase 2

Cardiovascular Diseases

ALD-301

Phase 2

Peripheral Artery Disease

rAAV1-CMV-GAA (study agent) Administration

Phase 2

Pompe Disease

Statin (rosuvastatin 10 or 40 mg daily, depending on risk)

Phase 2

Lipid Disorder

Ifetroban Sodium

Phase 2

Cardiovascular Diseases

Measures performed on all subjects

Phase 2

Ischemic Stroke

Ex Vivo-Expanded Cord Blood Progenitor Cell Infusion

Phase 2

Acute Biphenotypic Leukemia

Valsartan 40 mg

Phase 2

Pulmonary Arterial Hypertension

Flecainide Pill

Phase 2

Arrhythmogenic Right Ventricular Cardiomyopathy

Thiotepa

Phase 2

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive

RVX000222

Phase 2

Diabetes

VIA-2291

Phase 2

Acute Coronary Syndrome

Hyperpolarized 129-Xenon gas

Phase 2

Radiation Injury

r-ATG

Phase 2

Sickle Cell Disease

Metoprolol Succinate ER

Phase 2

Healthy

Dilanubicel

Phase 2

Acute Biphenotypic Leukemia

Sodium Bicarbonate

Phase 2

Chronic Kidney Disease

Nebulized Sodium Nitrite

Phase 2

Heart Failure

CTX-100 (formerly ETX-100) (hyaluronic acid)

Phase 2

Chronic Obstructive Pulmonary Disease (COPD)

Peginterferon Alfa-2a and Ribavirin

Phase 2

Hepatitis C

Mometasone

Phase 2

Sickle Cell Disease

melatonin

Phase 2

Traumatic Brain Injury

HBI-002

Phase 2

Anemia, Sickle Cell

Spironolactone 25mg

Phase 2

Congenital Heart Disease

ALT-836

Phase 2

Sepsis

Haploidentical Bone Marrow Transplantation

Phase 2

Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

129Xe Hyperpolarized

Phase 2

Pulmonary Arterial Hypertension

L-Arginine

Phase 2

Asthma

recombinant human CC10 (rhCC10)

Phase 2

Respiratory Distress Syndrome in Premature Infant

Ibutilide

Phase 2

Prolonged QT Interval in EKG and Sudden Death

Suvorexant

Phase 2

Sleep Disturbance

Nitric Oxide

Phase 2

Anemia, Sickle Cell

Ad5.hAC6

Phase 2

Congestive Heart Failure

CD34+ Hematopoietic Progenitor Cells (HSPC)

Phase 2

Myeloid Leukemia, Chronic

Milrinone

Phase 2

Valvular Stenosis

Aerosol Interferon-Gamma

Phase 2

Tuberculosis

Astatine At 211 Anti-CD45 Monoclonal Antibody BC8-B10

Phase 2

Non-Malignant Neoplasm

6R-BH4

Phase 2

Renal Insufficiency, Chronic

Iocide Oral Rinse

Phase 2

Gingivitis

Mesenchymal Stem Cells (MSC)

Phase 2

Ischemic Cardiomyopathy

100 million Allogeneic Mesenchymal Human Stem Cells

Phase 2

Diabetes Mellitus

Inhaled Nitric Oxide

Phase 2

Pulmonary Embolism

Nesiritide

Phase 2

Congestive Heart Failure

Minocycline

Phase 2

Hypertension

Dronabinol

Phase 2

Sickle Cell Disease

Bosentan

Phase 2

Type 2 Diabetes Mellitus

Hematopoietic Stem Cell Transplantation

Phase 2

Sickle Cell Disease

Adult stem cells

Phase 2

Chronic Ischemic Heart Disease

PZ-128

Phase 2

Arterial Occlusive Diseases

Acetazolamide

Phase 2

Sleep-Disordered Breathing

Atorvastatin Calcium

Phase 2

Malignant Neoplasm

Fish oil (eicosapentaenoic acid and docosahexanoic acid)

Phase 2

Respiratory Distress Syndrome, Adult

Recombinant human erythropoietin alfa (drug)

Phase 2

Healthy Subjects

20 million Allogeneic Mesenchymal Human Stem Cells

Phase 2

Diabetes Mellitus, Type 2

Sertraline, citalopram, or bupropion

Phase 2

Acute Coronary Syndrome

Hyperpolarized Xenon129

Phase 2

Lung Transplant Rejection

Stratified medicine - Microvascular dysfunction and eplerenone therapy, tablets

Phase 2

Myocardial Infarction, Acute

Metformin hydrochloride extended-release tablets

Phase 2

Asthma

L-ctirulline

Phase 2

Asthma

MCT

Phase 2

Asthma

Essential Amino Acids Supplementation intervention

Phase 2

Metabolic-dysfunction Associated Steatotic Liver Disease

Bob's Red Mill®

Phase 2

Hematopoietic Stem Cell Transplantation

Red cell units that are genotype matched at the RHD and RHCE loci

Phase 2

Sickle Cells Disease

MVT-100

Phase 2

Heart Diseases

Spironolactone Pill

Phase 2

Intracerebral Hemorrhage

Roflumilast 500 Mcg Oral Tablet

Phase 2

Asthma

Acetazolamide 500 MG QHS

Phase 2

Obstructive Sleep Apnea

anti-thymocyte globulin

Phase 2

Aplastic Anemia

Auto-hMSCs

Phase 2

Stem Cell Transplantation

Fluticasone

Phase 2

Bronchiolitis Obliterans Syndrome

Decitabine (USAN, INN)

Phase 2

Thalassemia

Sodium Nitrite

Phase 2

Heart Failure

Vigabatrin Only Product

Phase 2

Status Epilepticus, Electrographic

Arginine

Phase 2

Anemia, Sickle Cell

SelG1

Phase 2

Sickle Cell Disease

Atomoxetine and oxybutynin (ato-oxy)

Phase 2

Obstructive Sleep Apnea

Trivirus Specific CTLs for EBV, CMV and Adenovirus Infection

Phase 2

Adenovirus Infection

HXe MRI lung ventilation

Phase 2

Asthma

Celecoxib

Phase 2

Lymphangioleiomyomatosis (LAM)

extended-release niacin (Niaspan)

Phase 2

Aortocoronary Saphenous Vein Bypass Graft Atherosclerosis

Isosorbide Mononitrate

Phase 2

Heart Failure

Imaging with flutemetamol F 18 PET/CT

Phase 2

Cognitive Impairment

Slow Release DHEA

Phase 2

Asthma

Conditioning Regimen with Bone Marrow Transplant

Phase 2

Sickle Cell Disease

Thiamine

Phase 2

Coronary Artery Bypass

Cyclophosphamide 150mg

Phase 2

Anemia, Aplastic

Tretinoin and Arsenic Trioxide

Phase 2

Acute Promyelocytic Leukemia

Minocycline 50mg/d

Phase 2

Hypertension

Hematopoietic Stem Cell Transplant

Phase 2

Lymphoma, Non-Hodgkin

Midodrine

Phase 2

Sepsis

MPC Intramyocardial injection

Phase 2

Heart Failure

Eplerenone 100 mg daily

Phase 2

Hypertension

Furosemide

Phase 2

Heart Failure

Carnosine

Phase 2

Peripheral Arterial Disease

Clofazimine

Phase 2

Mycobacterium Avium Complex

Treosulfan

Phase 2

Bone Marrow Failure Syndrome

Famotidine 20 MG

Phase 2

Pulmonary Arterial Hypertension

Deferiprone Tablets

Phase 2

Acute Myocardial Infarction Type 1

[68Ga]CBP8

Phase 2

Interstitial Lung Disease

Liothyronine

Phase 2

Heart Failure With Reduced Ejection Fraction (HFrEF)

0.9% Sodium Chloride 250 mL bolus

Phase 2

Blunt Trauma

Propranolol

Phase 2

Sickle Cell Disease

CXA-10

Phase 2

Asthma

Trikafta

Phase 2

Cystic Fibrosis

S-equol

Phase 2

Chronic Kidney Diseases

Aminophylline (250mg IV +/- a second dose of 250mg IV)

Phase 2

Cardiac Arrest

Healthy

1 drug in this indication

Sickle Cell Disease

1 drug in this indication

Chronic Kidney Disease

1 drug in this indication

Covid19

1 drug in this indication

Acute Biphenotypic Leukemia

1 drug in this indication

Heart Failure

1 drug in this indication

Emphysema

1 drug in this indication

Pediatric Pulmonary Hypertension

1 drug in this indication

Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)

📑
Catalyst DossierPRO
The full research note — thesis, the if-approved scenario, financials & smart money. Compiled by CeliA.
→
Market-Implied Move
Regulatory Approvals

Frequently asked questions

What is in HeartSciences Inc.'s drug pipeline?→

CatalystAlert tracks 238 drug candidates in HeartSciences Inc.'s (HSCSW) pipeline across Phase 3, Phase 2. Its lead program is Aspirin 81mg (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is HeartSciences Inc.'s next FDA catalyst?→

CatalystAlert tracks every upcoming catalyst for HeartSciences Inc. (HSCSW) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.

How do I track HSCSW biotech catalysts?→

Add HSCSW to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow HeartSciences Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.

Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply